| Application no. and date | 19714799.4 (espacenet) (Federated) (European Patent Register), 20190312 | | Patent/reg. no. and date | DK/EP 3765013, 20240703 | | Publication date | 20210120 | | Priority no. and date | IT 201800003449, 20180312 | | EP pub. no. and date |
EP 3765013 20210120 | | Effective date | | | Applicant/owner | Istituto Oncologico Veneto IOV-IRCCS, Via Gattamelata 64
35128 Padova, IT | | Applicant ref. no. | | | Inventor | INDRACCOLO, Stefano, c/o Istituto Oncologico Veneto IOV-IRCCS
Via Gattamelata, 64
35128 Padova, IT,
DE SALVO, Gian Luca, c/o Istituto Oncologico Veneto IOV-IRCCS
Via Gattamelata, 64
35128 Padova, IT,
LOMBARDI, Giuseppe, c/o Istituto Oncologico Veneto IOV-IRCCS
Via Gattamelata, 64
35128 Padova, IT | | Representative | | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 38/43 (2006.01) , A61P 35/00 (2006.01) , C07K 16/40 (2006.01) , G01N 33/50 (2006.01) , G01N 33/574 (2006.01) | | Title | MARKER FOR IDENTIFYING PATIENTS WITH GLIOBASTOMA WHO RESPOND POSITIVELY TO THE DRUG REGORAFENIB | | Int. application no. | IB2019051991 | | Int. publication no. | WO2019175763 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
